Xeloda Important Drug Warning: Stevens
... Further information on the safety concern and recommendations SJS and TEN are considered to represent variants within a continuous spectrum of skin disorders characterized by generalized tender erythematous maculae progressing to blisters and denudation, and often preceded by photophobia, symptoms o ...
... Further information on the safety concern and recommendations SJS and TEN are considered to represent variants within a continuous spectrum of skin disorders characterized by generalized tender erythematous maculae progressing to blisters and denudation, and often preceded by photophobia, symptoms o ...
Once-Daily Tedizolid Effective for Acute Skin Infections Veronica
... hospital and outpatient settings." Drug-resistant bacterial infections caused by Gram-positive bacteria have emerged as a major public health problem. Methicillin-resistant Staphylococcus aureus (MRSA) infections, in particular, have high rates of treatment failure, whereas the limitations of curren ...
... hospital and outpatient settings." Drug-resistant bacterial infections caused by Gram-positive bacteria have emerged as a major public health problem. Methicillin-resistant Staphylococcus aureus (MRSA) infections, in particular, have high rates of treatment failure, whereas the limitations of curren ...
2013_Adverse effects..
... • Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. • However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs ...
... • Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. • However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs ...
Bronchitis and Pneumonia Drugs
... heart failure, asthma, bronchitis, or other chronic lung diseases. It should be used with caution in animals with severe heart disease, abnormal heart rhythms, kidney or liver impairment, or high blood pressure. Theophylline has been shown to cause stomach irritation and nervous system stimulation. ...
... heart failure, asthma, bronchitis, or other chronic lung diseases. It should be used with caution in animals with severe heart disease, abnormal heart rhythms, kidney or liver impairment, or high blood pressure. Theophylline has been shown to cause stomach irritation and nervous system stimulation. ...
Antibiotic Prescribing Trends in U.S. Hospitals Raise Flags
... toward using broad-spectrum agents is cause for concern, because these types of antibiotics have been shown to significantly increase the risk of drug-resistant infections.1 Another worrisome trend is that fluoroquinolones were the most commonly prescribed class of antibiotics in hospitals, accounti ...
... toward using broad-spectrum agents is cause for concern, because these types of antibiotics have been shown to significantly increase the risk of drug-resistant infections.1 Another worrisome trend is that fluoroquinolones were the most commonly prescribed class of antibiotics in hospitals, accounti ...
![[XENAZINE® (tetrabenazine) Tablets] Indications and Usage](http://s1.studyres.com/store/data/005705040_1-c465aacaeb05ad82ec88906235858f20-300x300.png)
[XENAZINE® (tetrabenazine) Tablets] Indications and Usage
... include immediate discontinuation of XENAZINE and other drugs not essential to concurrent therapy. • XENAZINE can also cause other serious side effects, including: akathisia, restlessness, agitation, parkinsonism, and sedation/somnolence. These side effects may require a dose reduction or discontinu ...
... include immediate discontinuation of XENAZINE and other drugs not essential to concurrent therapy. • XENAZINE can also cause other serious side effects, including: akathisia, restlessness, agitation, parkinsonism, and sedation/somnolence. These side effects may require a dose reduction or discontinu ...
1301 Pharmacology Drug List
... (competitive antagonism); drug has no pharmacologic activity of its own. Major Contraindications/Cautions: 1. Contraindicated in patients hypersensitive to drug. 2. Use cautiously in patients with cardiac irritability or opioid addiction. Abrupt reversal of opioid-induced CNS depression may result i ...
... (competitive antagonism); drug has no pharmacologic activity of its own. Major Contraindications/Cautions: 1. Contraindicated in patients hypersensitive to drug. 2. Use cautiously in patients with cardiac irritability or opioid addiction. Abrupt reversal of opioid-induced CNS depression may result i ...
File - the Drug Card Database
... Slowed progression of diabetic nephropathy (irbesartan and losartan only). Reduced cardiovascular death and hospitalizations due to CHF in patients with CHF (candesartan and valsartan only). Decreased risk of cardiovascular death in patients with left ventricular systolic dysfunction who are post-MI ...
... Slowed progression of diabetic nephropathy (irbesartan and losartan only). Reduced cardiovascular death and hospitalizations due to CHF in patients with CHF (candesartan and valsartan only). Decreased risk of cardiovascular death in patients with left ventricular systolic dysfunction who are post-MI ...
Gliptins: disabling joint pain
... effects (2). On the one hand they provoke hypersensitivity reactions, and on the other hand they have immunosuppressant effects and increase the risk of infection, in particular urinary and upper respiratory tract infections. These apparently inflammatory gliptin-associated joint disorders may shar ...
... effects (2). On the one hand they provoke hypersensitivity reactions, and on the other hand they have immunosuppressant effects and increase the risk of infection, in particular urinary and upper respiratory tract infections. These apparently inflammatory gliptin-associated joint disorders may shar ...
extrapyramidal reactions - Prescrire International
... effects (2). On the one hand they provoke hypersensitivity reactions, and on the other hand they have immunosuppressant effects and increase the risk of infection, in particular urinary and upper respiratory tract infections. These apparently inflammatory gliptin-associated joint disorders may shar ...
... effects (2). On the one hand they provoke hypersensitivity reactions, and on the other hand they have immunosuppressant effects and increase the risk of infection, in particular urinary and upper respiratory tract infections. These apparently inflammatory gliptin-associated joint disorders may shar ...
Refla™ (Deflazacort)
... Elderly: In elderly patients, no special precautions other than those usually adopted in patients receiving glucocorticoid therapy are necessary. The common adverse effects of systemic corticosteroids may be associated with more serious consequences in old age. Children: There has been limited expos ...
... Elderly: In elderly patients, no special precautions other than those usually adopted in patients receiving glucocorticoid therapy are necessary. The common adverse effects of systemic corticosteroids may be associated with more serious consequences in old age. Children: There has been limited expos ...
Flupentixol + Melitracen
... Description: Adelax¨ is a combination preparation of two well known and time tested molecules: flupentixol - a neuroleptic with anxiolytic and antidepressant properties of its own when given in small doses, and melitracen - a bipolar thymoleptic with activating properties in low doses. In combinatio ...
... Description: Adelax¨ is a combination preparation of two well known and time tested molecules: flupentixol - a neuroleptic with anxiolytic and antidepressant properties of its own when given in small doses, and melitracen - a bipolar thymoleptic with activating properties in low doses. In combinatio ...
2008 April - GeriatRx Pharmacy
... consumption of only a small volume of liquid. The active ingredient in Oral Fleet® is sodium phosphate. This drug, which is also found in Fleet® Enema, is not to be used in individuals with renal impairment. These people are unable to clear the excess phosphate from their system, and a dangerous ele ...
... consumption of only a small volume of liquid. The active ingredient in Oral Fleet® is sodium phosphate. This drug, which is also found in Fleet® Enema, is not to be used in individuals with renal impairment. These people are unable to clear the excess phosphate from their system, and a dangerous ele ...
Lacosamide (Vimpat®)
... days from baseline to the maintenance period for both the lacosamide 200mg/day group (14.4%; p=0.02) and the 400mg/day group (15%; p=0.03). The 50% response rate for lacosamide 400mg/day (40.5%) was statistically significant (p=0.01) over placebo (25.8%). A statistically significant increase of 5% i ...
... days from baseline to the maintenance period for both the lacosamide 200mg/day group (14.4%; p=0.02) and the 400mg/day group (15%; p=0.03). The 50% response rate for lacosamide 400mg/day (40.5%) was statistically significant (p=0.01) over placebo (25.8%). A statistically significant increase of 5% i ...
ANTIMICOBACTERIAL DRUGS
... • A six month of drugs for DOTS costs US 11 dollars per patients in some parts of the world. The world Bank has ranked the DOTS strategy as one of the most cost effective of all health interventions. ...
... • A six month of drugs for DOTS costs US 11 dollars per patients in some parts of the world. The world Bank has ranked the DOTS strategy as one of the most cost effective of all health interventions. ...
Frenxit Prescribing Information
... Adults : Usually 2 tablets daily (morning and noon). In severe cases the morning dose may be increased to 2 tablets. Elderly patients : 1 tablet in the morning. Maintenance dose : Usually 1 tablet in the morning. In cases of insomnia or severe restlessness additional treatment with a sedative in the ...
... Adults : Usually 2 tablets daily (morning and noon). In severe cases the morning dose may be increased to 2 tablets. Elderly patients : 1 tablet in the morning. Maintenance dose : Usually 1 tablet in the morning. In cases of insomnia or severe restlessness additional treatment with a sedative in the ...
Low blood pressure and orthostatic hypotension as an adverse
... potency antipsychotics such as, for instance, chlorpromazine and thioridazine. These problems usually develop very early, often after the first dose of an antipsychotic. Orthostatic hypotension has also been reported with second generation antipsychotics. It is a common adverse event of higher doses ...
... potency antipsychotics such as, for instance, chlorpromazine and thioridazine. These problems usually develop very early, often after the first dose of an antipsychotic. Orthostatic hypotension has also been reported with second generation antipsychotics. It is a common adverse event of higher doses ...
Important Safety Information
... hypercalcemia, urticaria, and exacerbation of psoriasis. Patients who apply Enstilar® to exposed skin should avoid excessive exposure to either natural or artificial sunlight, including tanning booths, sun lamps, etc. You may wish to limit or avoid use of phototherapy in patients who use Enstilar®. ...
... hypercalcemia, urticaria, and exacerbation of psoriasis. Patients who apply Enstilar® to exposed skin should avoid excessive exposure to either natural or artificial sunlight, including tanning booths, sun lamps, etc. You may wish to limit or avoid use of phototherapy in patients who use Enstilar®. ...
Slide 1
... Interim bridging to provide access ahead of new evidence – not a permanent reimbursement ...
... Interim bridging to provide access ahead of new evidence – not a permanent reimbursement ...
BETAHISTINE HYDROCHL ORIDE
... are very low, pharmacokinetic analyses are therefore based on 2-PAA measurements in plasma and urine. Peak plasma concentrations of 2-PAA achieved one hour after oral administration in fasting subjects and declines with a half-life of about 3.5 hours. Tissue distribution of betahistine in humans is ...
... are very low, pharmacokinetic analyses are therefore based on 2-PAA measurements in plasma and urine. Peak plasma concentrations of 2-PAA achieved one hour after oral administration in fasting subjects and declines with a half-life of about 3.5 hours. Tissue distribution of betahistine in humans is ...
Sulfin® Tablets 100 mg
... animals have yielded inconclusive results. Up to the present time, however, there have been no reported cases of human congenital malformation proved to be due to the use of the drug. It is suggested that Sulfin be used with caution in pregnant women, weighing the potential risks against the possibl ...
... animals have yielded inconclusive results. Up to the present time, however, there have been no reported cases of human congenital malformation proved to be due to the use of the drug. It is suggested that Sulfin be used with caution in pregnant women, weighing the potential risks against the possibl ...
Cinnarizine tablets Therapeutic indications Cinnarizine is
... nausea and vomiting such as is seen in Meniere's Disease. Cinnarizine is also effective in the control of motion sickness. ...
... nausea and vomiting such as is seen in Meniere's Disease. Cinnarizine is also effective in the control of motion sickness. ...
Lithium - Wellington ICU
... element of the alkali metal group exact mechanism of action in mania is unknown ? alters Na+ transport in muscle and nerves cells ? alters intraneuronal metabolism of catecholamines ...
... element of the alkali metal group exact mechanism of action in mania is unknown ? alters Na+ transport in muscle and nerves cells ? alters intraneuronal metabolism of catecholamines ...
IMPORTANT SAFETY INFORMATION WARNING: RISK OF
... cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use [see Warnings and Precautions (5.1)]. TREXIMET® is contraindicated in the setting of coronary artery bypass graft (CABG) surg ...
... cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use [see Warnings and Precautions (5.1)]. TREXIMET® is contraindicated in the setting of coronary artery bypass graft (CABG) surg ...
Ofloxacin
Ofloxacin is a synthetic antibiotic of the fluoroquinolone drug class considered to be a second-generation fluoroquinolone.Ofloxacin was first patented in 1982 (European Patent Daiichi) and received approval from the U.S. Food and Drug Administration (FDA) on December 28, 1990. Ofloxacin is sold under a wide variety of brand names as well as generic drug equivalents, for oral and intravenous administration. Ofloxacin is also available for topical use, as eye drops and ear drops (marketed as Ocuflox and Floxin Otic respectively in the United States and marketed as Optiflox, eylox respectively in Jordan and Saudi Arabia).Ofloxacin is a racemic mixture, which consists of 50% levofloxacin (the biologically active component) and 50% of its “mirror image” or enantiomer dextrofloxacin.Ofloxacin has been associated with adverse drug reactions, such as tendon damage (including spontaneous tendon ruptures) and peripheral neuropathy (which may be irreversible); tendon damage may manifest long after therapy had been completed, and, in severe cases, may result in lifelong disabilities.